← Leaderboards
Pepper J Schedin
Amc Cancer Research Center
$5,332,333
Attributed
$7,584,345
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $907.7K · FY2013–24$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,584,345 · 4
By mechanism
R01$7,473,045 · 3
R29$111,300 · 1
Top collaborators
- Virginia F. Borges6 shared
- Paul S Maclean5 shared
Most similar at Amc Cancer Research Center
Same institution · by research overlap
- Russell E Glasgow$13,872,887
- Junxuan Lu$11,268,028
- Addanki P Kumar$4,520,385
- Thomas J Slaga$5,933,051
- Irina V Budunova$8,782,023
Others in their field
Top investigators on “Pregnancy”
- Chanza Baytop · Westat, Inc.$271,217,917
- Carol Nesel · Westat$188,148,170
- Elizabeth A Thom · George Washington University$158,777,707
- Barbara Driver · Westat, Inc.$117,058,181
- Myron S Cohen · Family Health International$101,800,876
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
Research focus
PregnancyTissuesMalignant Breast NeoplasmTumorMammary GlandPreventHigh RiskBaseLactationMacrophageBreast Epithelial CellsAnti-Inflammatory AgentsIbuprofenImmuneBreast Cancer PreventionIncidenceBreastBreast Cancer DiagnosisDepositionCell DeathGlandDiagnosisHigh Risk WomanCancer Chemoprevention
Grant awards (22)
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention$365,848
R01 · FY2024 · CA · contact PI
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention$377,401
R01 · FY2023 · CA · contact PI
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention$379,238
R01 · FY2022 · CA · contact PI
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention$390,917
R01 · FY2021 · CA · contact PI
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention$390,917
R01 · FY2020 · CA · contact PI
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention$563,847
R01 · FY2017 · CA · contact PI
A Narrowed Window for Targeting Metabolic Flexibility in Breast Cancer Prevention$322,663
R01 · FY2017 · CA
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention$579,176
R01 · FY2016 · CA · contact PI
A Narrowed Window for Targeting Metabolic Flexibility in Breast Cancer Prevention$322,663
R01 · FY2016 · CA
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention$585,429
R01 · FY2015 · CA · contact PI
A Narrowed Window for Targeting Metabolic Flexibility in Breast Cancer Prevention$322,230
R01 · FY2015 · CA
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention$532,625
R01 · FY2014 · CA · contact PI
A Narrowed Window for Targeting Metabolic Flexibility in Breast Cancer Prevention$308,358
R01 · FY2014 · CA
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention$59,330
R01 · FY2014 · CA · contact PI
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention$597,993
R01 · FY2013 · CA · contact PI
A Narrowed Window for Targeting Metabolic Flexibility in Breast Cancer Prevention$309,710
R01 · FY2013 · CA
Endocrine Status of MG Stroma Alters Breast CA Invasion$207,859
R01 · FY2004 · CA
Endocrine Status of MG Stroma Alters Breast CA Invasion$58,316
R01 · FY2004 · CA
Endocrine Status of MG Stroma Alters Breast CA Invasion$266,175
R01 · FY2003 · CA
Endocrine Status of MG Stroma Alters Breast CA Invasion$266,175
R01 · FY2002 · CA
Endocrine Status of MG Stroma Alters Breast CA Invasion$266,175
R01 · FY2001 · CA
ECM MEDIATORS OF CHEMOPREVENTIVE AGENTS IN THE BREAST$111,300
R29 · FY2000 · CA